Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule classified as a phenol ether and dichlorobenzene derivative. It features an aromatic ether group substituted with a benzene ring and contains both isoxazole and oxazoline moieties. The compound has been referenced under the code name "Compound WIN VIII" and has not been approved for any clinical use or indication. Its primary known biological activity is targeting the protein genome polyprotein; however, no detailed mechanism of action or therapeutic application in humans has been established. It remains an experimental molecule with no associated clinical trials or regulatory approvals[1][2][4].
- Other names
- 2-[[5-[5-[2,6-dichloro-4-(4,5-dihydrooxazol-2-yl)phenoxy]pentyl]isoxazol-3-yl]methoxymethoxy]ethanol
Beyond the preview
Go deeper on 5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole.